Chem. J. Chinese Universities ›› 2020, Vol. 41 ›› Issue (2): 262.doi: 10.7503/cjcu20190483

• Analy Chemistry • Previous Articles     Next Articles

Analysis of Imidazole Propionic Acid in Serum of Patients with Type 2 Diabetes Based on NiO@SiO2 Solid-phase Extraction Coupled with Liquid Chromatography-Mass Spectrometry

WANG Tianqi,YU Qiongwei(),FENG Yuqi()   

  1. Key Laboratory of Analytical Chemistry for Biology and Medicine, Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan 430072, China
  • Received:2019-09-10 Online:2020-02-10 Published:2019-11-04
  • Contact: Qiongwei YU,Yuqi FENG E-mail:qwyu@whu.edu.cn;yqfeng@whu.edu.cn
  • Supported by:
    ? Supported by the National Natural Science Foundation of China(31671929);Supported by the National Natural Science Foundation of China(31670373)

Abstract:

Imidazole propionic acid can cause insulin resistance in human through mammalian target of rapamycin complex 1(mTORC1) pathway, leading to type 2 diabetes(T2D). Therefore, the accurate quantification of imidazole propionic acid benefits for the diagnosis of type 2 diabetes. Based on the coordination between NiO and imidazole groups, NiO@SiO2 was used for the selective extraction of imidazole propionic acid in serum. Firstly, the NiO@SiO2 solid phase extraction(SPE) conditions were optimized as follows: the amount of absorbent was 200 mg, the loading solution was 20 mmol/L of phosphate buffer(pH=3.0) and 1.0 mL of aqueous solution containing 1% NH3·H2O was used as the elution. Then, a simple and effective method for the analysis of imidazole propionic acid in serum was established by coupling NiO@SiO2 solid phase extraction with high performance liquid chromatography-mass spectrometry(HPLC-MS). The linearity of the developed method was in the range of 0.05—10 ng/mL with a good linearity(R 2≥0.996). The LOD and LOQ were 0.02 and 0.05 ng/mL, respectively. The recovery was 84.0%—119%, and the relative standard deviation(RSD) was less than 17.2%. The established method was applied to the detection of imidazole propionic acid in patients with type 2 diabetes and normal subjects. There was a significant difference in imidazole propionic acid content between type 2 diabetic patients and normal subjects, indicating that accurate quantification of imidazole propionic acid has great potential in medical diagnosis.

Key words: Imidazolepropionic acid, NiO@SiO2, Type 2 diabetes, Solid phase extraction(SPE), High performance liquid chromatography-mass spectrometry(HPLC-MS)

CLC Number: 

TrendMD: